Search

everythinglearnresearchcommunity

for

Search:↓

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Women with acne have lower levels of a specific hormone marker than women without acne.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

Interest in acne is rising, but research funding has significantly decreased.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

People with severe acne tend to have higher levels of betatrophin.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Higher androgen levels do not cause baldness in men.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

Adipokines affect skin health and could be targeted for treating skin diseases.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Spironolactone is effective for treating acne, hirsutism, and androgenic alopecia in women with few side effects.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Many patients at a dermatology clinic had scalp problems, often unrelated to why they visited, suggesting scalp checks should be regular.

PCOS is a common hormonal disorder in women that can be managed with medication and lifestyle changes like exercise and weight control.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Microneedles help improve drug delivery through the skin and are used in medicine and beauty treatments.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

The document concludes that an inherited nail condition often improves on its own, and spironolactone effectively treats acne in women.